newsfilter
← Latest News
GlobeNewswire·

Chemomab Announces New Medical and Clinical Appointments

David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R&D, Drug Development and Strategic Experience Jack Lawler, Who Oversaw the